Byler Disease

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2019-02-18
Clinical Trial Update: Expanded Access Protocol for an Intermediate Size Population - RAVICTI for Byler Disease
The expanded access protocol for RAVICTI to treat Byler disease is no longer available.